SCHOTT Pharma AG & Co. KGaA

1SXP

DE000A3ENQ51

Medical Equipment, Supplies & Distribution

Market Closed - Xetra Other stock markets 11:35:38 2024-05-20 am EDT			After market 02:46:24 pm
30.34 ^EUR	-3.74%		30.33	-0.03%

08:50am	UBS lowers target for Schott Pharma to 33 euros - 'Neutral'	DP
08:24am	SCHOTT PHARMA : UBS reiterates its Neutral rating	ZD

SCHOTT PHARMA : Gets a Neutral rating from Barclays

May 10, 2024 at 02:54 am EDT

Analyst Gaurav Jain from Barclays research gives the stock a Neutral rating. The target price is unchanged and still at EUR 30.

Latest news about SCHOTT Pharma AG & Co. KGaA

UBS lowers target for Schott Pharma to 33 euros - 'Neutral'	02:50am	DP
SCHOTT PHARMA : UBS reiterates its Neutral rating	02:24am	ZD
Barclays lowers Schott Pharma target to 25 euros - 'Equal Weight'	May. 15	DP
SCHOTT PHARMA : Deutsche Bank reiterates its Buy rating	May. 15	ZD
SCHOTT PHARMA : Barclays remains Neutral	May. 15	ZD
Schott Pharma falls sharply - 'High dependence on end markets'	May. 15	DP
SCHOTT PHARMA : Gets a Neutral rating from UBS	May. 15	ZD
Schott Pharma warns of weak syringe sales - share price slide	May. 15	DP
Schott Pharma falls sharply	May. 15	DP
SCHOTT PHARMA : Jefferies reiterates its Neutral rating	May. 14	ZD
Schott Pharma warns of weak syringe sales in the coming year	May. 14	DP
UBS starts Schott Pharma with 'Neutral' - Target 40 euros	May. 14	DP
SCHOTT PHARMA : UBS from Sell to Neutral	May. 14	ZD
SCHOTT PHARMA : Buy rating from Deutsche Bank	May. 13	ZD
SCHOTT PHARMA : Gets a Neutral rating from Barclays	May. 10	ZD
SCHOTT PHARMA : Jefferies remains Neutral	Apr. 22	ZD
Gerresheimer very weak - Certain uncertainties about outlook	Apr. 11	DP
Weight-loss drug deals to drive around 4% of Gerresheimer yearly growth, CEO says	Mar. 29	RE
Berenberg starts Schott Pharma with 'Hold' - Target 38 Euro	Mar. 27	DP
SCHOTT PHARMA : Berenberg remains Neutral	Mar. 27	ZD
Dpa-AFX Overview: COMPANIES from 19.03.2024 - 15:15	Mar. 19	DP
Schott Pharma Plans New Syringe Manufacturing Facility in US	Mar. 19	MT
SCHOTT PHARMA : Jefferies reiterates its Neutral rating	Mar. 18	ZD
SCHOTT Pharma Announces to Expand in U.S. with New Prefillable Syringe Manufacturing Facility in Wilson, North Carolina	Mar. 18	CI
SCHOTT Pharma AG & Co. KGaA(XTRA:1SXP) added to S&P Global BMI Index	Mar. 17	CI

Chart SCHOTT Pharma AG & Co. KGaA

Duration

Period

More charts

SCHOTT Pharma AG & Co. KGaA is a Germany-based Company, which designs advanced drug containment and drug delivery solutions for the pharmaceutical and biotech industries. The Company's product portfolio ranges from drug containment solutions to drug delivery systems manufactured in collaboration with industry partners. Its selection of pharmaceutical syringes, cartridges, vials, and ampoules is one of the widest and advanced on the market for injectable drugs.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-06-26 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Ratings for SCHOTT Pharma AG & Co. KGaA

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

31.52 EUR

Average target price

37.2 EUR

Spread / Average Target

+18.02%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SCHOTT PHARMA AG & CO. KGAA	-9.70%	5.16B
ABBOTT LABORATORIES	-5.95%	181B
MEDTRONIC PLC	+2.96%	114B
BECTON, DICKINSON AND COMPANY	-3.01%	68.29B
DEXCOM, INC.	+5.60%	52.24B
CENCORA, INC.	+7.53%	44.3B
HOYA CORPORATION	+6.67%	42.73B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.22%	32.52B
TERUMO CORPORATION	+20.03%	26.02B
WEST PHARMACEUTICAL SERVICES, INC.	-2.24%	25.91B

Other Medical Equipment, Supplies & Distribution

SCHOTT Pharma AG & Co. KGaA

Equities

1SXP

DE000A3ENQ51

Medical Equipment, Supplies & Distribution

SCHOTT PHARMA : Gets a Neutral rating from Barclays

Latest news about SCHOTT Pharma AG & Co. KGaA

Chart SCHOTT Pharma AG & Co. KGaA

Company Profile

Income Statement Evolution

Ratings for SCHOTT Pharma AG & Co. KGaA

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution